Does Penicillium contain a treasure trove of undiscovered secondary metabolites?

PhRMA weeds out 22 members after revising membership rules.

Is growing awareness of unwanted drug effects good or bad for patients?

Charlotte Barker speaks with Lukas Utiger from Patheon.

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

We Sit Down With Daniel O'Connor, Medical Assessor at the MHRA, UK.

Biopharma manufacturing continues to advance and the demand for new innovations is constant.

Surface plasmon resonance has become a go-to tool for biotherapeutic characterization.

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.